(Bloomberg) — Alibaba (NYSE:BABA) Group Holding Ltd. is selling assets from medical devices to drugs for HK$10.6 billion ($1.4 billion) to a Hong Kong-listed unit that it’ll take control of and turn into its main healthcare arm. Alibaba unveiled a deal …
( read original story …)